| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of cytokine-based approaches to treat autoimmune disorders
|
Adorini, Luciano
|
|
2004
|
|
3 |
p. 275-280
6 p.
|
artikel
|
| 2 |
Activation of P-glycoprotein efflux transport ameliorates opioid CNS effects without diminishing analgesia
|
Gordon, Sharon M.
|
|
2009
|
|
3 |
p. 97-103
7 p.
|
artikel
|
| 3 |
Adenosine receptor antagonists and asthma
|
Nadeem, Ahmed
|
|
2006
|
|
3 |
p. 269-275
7 p.
|
artikel
|
| 4 |
Aldosterone synthase and mineralocorticoid receptors as targets in cardiovascular disease
|
Funder, John W.
|
|
2005
|
|
3 |
p. 231-235
5 p.
|
artikel
|
| 5 |
Alzheimer's disease: γ-secretase inhibitors
|
Imbimbo, Bruno P.
|
|
2008
|
|
3 |
p. 169-175
7 p.
|
artikel
|
| 6 |
Antibody treatment of ulcerative colitis
|
Vexler, Vladimir
|
|
2006
|
|
3 |
p. 353-360
8 p.
|
artikel
|
| 7 |
Anticytokine therapies in rheumatoid arthritis: from the pipette to the patient
|
Wells, Alvin F.
|
|
2004
|
|
3 |
p. 293-297
5 p.
|
artikel
|
| 8 |
Anti-inflammatory strategies for the treatment of multiple sclerosis – tryptophan catabolites may hold the key
|
Platten, Michael
|
|
2006
|
|
3 |
p. 401-408
8 p.
|
artikel
|
| 9 |
Antisense modulation of RNA processing as a therapeutic approach in cancer therapy
|
Spraggon, Lee
|
|
2013
|
|
3 |
p. e139-e148
nvt p.
|
artikel
|
| 10 |
Antisense oligonucleotide based drugs: progress and challenges
|
Bennett, C. Frank
|
|
2013
|
|
3 |
p. e105-e107
nvt p.
|
artikel
|
| 11 |
Antisense oligonucleotides as personalized medicine for Duchenne muscular dystrophy
|
van Deutekom, Judith C.
|
|
2013
|
|
3 |
p. e149-e156
nvt p.
|
artikel
|
| 12 |
Antisense therapies for cancer
|
MacLeod, A. Robert
|
|
2013
|
|
3 |
p. e157-e163
nvt p.
|
artikel
|
| 13 |
Antisense therapies for cardiovascular/metabolic diseases
|
Geary, Richard S.
|
|
2013
|
|
3 |
p. e165-e170
nvt p.
|
artikel
|
| 14 |
Approaches to the treatment of visceral pain
|
Bulmer, David C.E.
|
|
2007
|
|
3 |
p. 171-176
6 p.
|
artikel
|
| 15 |
Atrial selective strategies for treating atrial fibrillation
|
Van Wagoner, David R.
|
|
2005
|
|
3 |
p. 291-295
5 p.
|
artikel
|
| 16 |
Biomarkers in cancer management: a crucial bridge toward personalized medicine
|
Gonçalves, Anthony
|
|
2004
|
|
3 |
p. 305-311
7 p.
|
artikel
|
| 17 |
Cell transplantation for the treatment of heart failure
|
Vilquin, Jean-Thomas
|
|
2005
|
|
3 |
p. 271-278
8 p.
|
artikel
|
| 18 |
Challenges and opportunities associated with targeting estrogen receptors in treating hypertension and cardiovascular disease
|
Dantas, Ana Paula V.
|
|
2005
|
|
3 |
p. 245-251
7 p.
|
artikel
|
| 19 |
Chemokines and chemokine receptors: Large and small therapeutic strategies for inflammatory diseases
|
Das, Anuk M.
|
|
2006
|
|
3 |
p. 381-388
8 p.
|
artikel
|
| 20 |
Clinical development of synthetic siRNA therapeutics
|
Thompson, James D.
|
|
2013
|
|
3 |
p. e133-e138
nvt p.
|
artikel
|
| 21 |
Clinical immunotherapy trials in Alzheimer’s disease
|
Hawkes, Cheryl A.
|
|
2008
|
|
3 |
p. 177-183
7 p.
|
artikel
|
| 22 |
Cognitive enhancing drugs for schizophrenia
|
Raedler, Thomas J.
|
|
2008
|
|
3 |
p. 145-150
6 p.
|
artikel
|
| 23 |
Contents
|
|
|
2009
|
|
3 |
p. i-
1 p.
|
artikel
|
| 24 |
Contents
|
|
|
2013
|
|
3 |
p. i-
1 p.
|
artikel
|
| 25 |
Contents
|
|
|
2008
|
|
3 |
p. i-
1 p.
|
artikel
|
| 26 |
Contents
|
|
|
2006
|
|
3 |
p. i-ii
nvt p.
|
artikel
|
| 27 |
Contents
|
|
|
2004
|
|
3 |
p. i-ii
nvt p.
|
artikel
|
| 28 |
Contents
|
|
|
2007
|
|
3 |
p. i-
1 p.
|
artikel
|
| 29 |
Corticosteroids: limitations and future prospects for treatment of severe inflammatory disease
|
Adcock, Ian M.
|
|
2004
|
|
3 |
p. 321-328
8 p.
|
artikel
|
| 30 |
CRF1 receptor antagonists: treatment of stress-related disorders
|
Kehne, John H.
|
|
2008
|
|
3 |
p. 161-168
8 p.
|
artikel
|
| 31 |
Cystic fibrosis: potential options for gene-directed therapies
|
Moraes, Theo J.
|
|
2004
|
|
3 |
p. 345-349
5 p.
|
artikel
|
| 32 |
Dendritic cells in Asthma: A target for novel therapeutics?
|
van Rijt, Leonie S.
|
|
2006
|
|
3 |
p. 299-307
9 p.
|
artikel
|
| 33 |
Drug targets modulating the gut-appetite-metabolism axis
|
Näslund, Erik
|
|
2007
|
|
3 |
p. 189-193
5 p.
|
artikel
|
| 34 |
Editorial
|
|
|
2005
|
|
3 |
p. 177-179
3 p.
|
artikel
|
| 35 |
Emerging therapies and novel approaches to visceral pain
|
Wesselmann, Ursula
|
|
2009
|
|
3 |
p. 89-95
7 p.
|
artikel
|
| 36 |
Employment of microRNA profiles and RNA interference and antagomirs for the characterization and treatment of respiratory disease
|
Yang, Ming
|
|
2006
|
|
3 |
p. 325-332
8 p.
|
artikel
|
| 37 |
Erratum: Progress in antifungal therapy: Echinocandins versus azoles
|
Nailor, Michael D.
|
|
2006
|
|
3 |
p. 409-
1 p.
|
artikel
|
| 38 |
Fighting pulmonary fibrosis: new science brings new therapeutic opportunities
|
Das, Anuk M.
|
|
2004
|
|
3 |
p. 361-368
8 p.
|
artikel
|
| 39 |
2020 foresight: Envisioning therapeutic innovations for pain
|
Hamza, May
|
|
2009
|
|
3 |
p. 113-119
7 p.
|
artikel
|
| 40 |
Future antidepressant targets: neurotrophic factors and related signaling cascades
|
Schmidt, Heath D.
|
|
2008
|
|
3 |
p. 151-156
6 p.
|
artikel
|
| 41 |
Gastrointestinal diseases
|
Sanger, Gareth J.
|
|
2007
|
|
3 |
p. 153-154
2 p.
|
artikel
|
| 42 |
Immune response modifiers: Imiquimod and future drugs for modulating the immune response
|
Tomai, Mark A.
|
|
2006
|
|
3 |
p. 343-352
10 p.
|
artikel
|
| 43 |
Immune tolerance as a strategy for treatment of atherosclerosis
|
Shovman, Ora
|
|
2005
|
|
3 |
p. 207-211
5 p.
|
artikel
|
| 44 |
Immunotargeting: A biological approach to the treatment of psoriasis
|
Baker, Barbara S.
|
|
2007
|
|
3 |
p. 201-207
7 p.
|
artikel
|
| 45 |
Individualized pain medicine
|
Kim, Hyungsuk
|
|
2009
|
|
3 |
p. 83-87
5 p.
|
artikel
|
| 46 |
Inhaled antisense oligonucleotide therapies: Inspiration and progress
|
Karras, James G.
|
|
2006
|
|
3 |
p. 335-341
7 p.
|
artikel
|
| 47 |
Interactions between long-acting β2-agonists and glucocorticoids
|
Caramori, Gaetano
|
|
2006
|
|
3 |
p. 261-268
8 p.
|
artikel
|
| 48 |
Isoprostanes and asthma
|
Montuschi, Paolo
|
|
2006
|
|
3 |
p. 287-292
6 p.
|
artikel
|
| 49 |
Is the P2Y1 receptor a better target for antithrombotic drugs?
|
Shankar, Haripriya
|
|
2005
|
|
3 |
p. 285-290
6 p.
|
artikel
|
| 50 |
Is there a need to identify new anti-emetic drugs?
|
Horn, Charles C.
|
|
2007
|
|
3 |
p. 183-187
5 p.
|
artikel
|
| 51 |
L-selectin in inflammation, infection and immunity
|
Raffler, Nikolai A.
|
|
2005
|
|
3 |
p. 213-220
8 p.
|
artikel
|
| 52 |
Major advances in ankylosing spondylitis: more to come
|
Maksymowych, Walter P.
|
|
2004
|
|
3 |
p. 383-387
5 p.
|
artikel
|
| 53 |
Modern H1-antihistamines in asthma
|
Borade, Prashant S.
|
|
2006
|
|
3 |
p. 253-259
7 p.
|
artikel
|
| 54 |
Modulation of neuroimmune axis and treatment of gastrointestinal diseases
|
Theodorou, Vassilia
|
|
2007
|
|
3 |
p. 177-182
6 p.
|
artikel
|
| 55 |
Molecular roles of Cdk5 in pain signaling
|
Utreras, Elias
|
|
2009
|
|
3 |
p. 105-111
7 p.
|
artikel
|
| 56 |
Natural antisense transcripts as therapeutic targets
|
Halley, Paul
|
|
2013
|
|
3 |
p. e119-e125
nvt p.
|
artikel
|
| 57 |
Neurogenic factors are targets in depression
|
Taupin, Philippe
|
|
2008
|
|
3 |
p. 157-160
4 p.
|
artikel
|
| 58 |
New anti-inflammatory approaches in COPD
|
Matera1 , Maria Gabriella
|
|
2004
|
|
3 |
p. 335-343
9 p.
|
artikel
|
| 59 |
New drugs to suppress acid secretion: current and future developments
|
Scarpignato, Carmelo
|
|
2007
|
|
3 |
p. 155-163
9 p.
|
artikel
|
| 60 |
Nitric-oxide based nonsteroidal anti-inflammatory agents
|
Ongini, Ennio
|
|
2006
|
|
3 |
p. 395-400
6 p.
|
artikel
|
| 61 |
Novel approaches and clinical opportunity for gastrointestinal prokinetic drugs
|
Borman, Richard A.
|
|
2007
|
|
3 |
p. 165-170
6 p.
|
artikel
|
| 62 |
Pain
|
Carney, Steve L.
|
|
2009
|
|
3 |
p. 81-82
2 p.
|
artikel
|
| 63 |
Passive immunotherapies for Alzheimer’s disease
|
Solomon, Beka
|
|
2008
|
|
3 |
p. 185-189
5 p.
|
artikel
|
| 64 |
Peroxisome Proliferator-Activated Receptor β/δ: A novel target for the reduction of atherosclerosis
|
Gross, Barbara S.
|
|
2005
|
|
3 |
p. 237-243
7 p.
|
artikel
|
| 65 |
Psychiatric disorders
|
Iversen, Leslie L.
|
|
2008
|
|
3 |
p. 143-144
2 p.
|
artikel
|
| 66 |
Pulmonary arterial hypertension: building a better mouse trap for 2010
|
White, R. James
|
|
2004
|
|
3 |
p. 351-359
9 p.
|
artikel
|
| 67 |
Renin inhibitors: An antihypertensive strategy on the verge of reality
|
Hershey, James C.
|
|
2005
|
|
3 |
p. 181-185
5 p.
|
artikel
|
| 68 |
RNA directed therapeutics: mechanisms and status
|
Crooke, Stanley T.
|
|
2013
|
|
3 |
p. e109-e117
nvt p.
|
artikel
|
| 69 |
Role of anti-oxidants in the treatment of bronchial asthma
|
Riccioni, Graziano
|
|
2006
|
|
3 |
p. 293-298
6 p.
|
artikel
|
| 70 |
Ryanodine receptors as drug targets for heart failure and cardiac arrhythmias
|
Lehnart, Stephan E.
|
|
2005
|
|
3 |
p. 259-269
11 p.
|
artikel
|
| 71 |
Selective inhibition of NADPH-oxidase isoforms as a therapeutic strategy in hypertension
|
Miller, Alyson A.
|
|
2005
|
|
3 |
p. 187-192
6 p.
|
artikel
|
| 72 |
Sleep apnea: impact on cardiovascular diseases
|
Naughton, Matthew T.
|
|
2004
|
|
3 |
p. 329-334
6 p.
|
artikel
|
| 73 |
Strategies targeting fibrosis in pulmonary disease
|
Ask, Kjetil
|
|
2006
|
|
3 |
p. 389-394
6 p.
|
artikel
|
| 74 |
Targeting heme oxygenase-1 in the treatment of atherosclerosis
|
Durante, William
|
|
2005
|
|
3 |
p. 201-206
6 p.
|
artikel
|
| 75 |
Targeting inflammatory disease
|
Braddock, Martin
|
|
2006
|
|
3 |
p. 333-334
2 p.
|
artikel
|
| 76 |
Targeting matrix remodeling in cardiac hypertrophy and heart failure
|
Lindsey, Merry L.
|
|
2005
|
|
3 |
p. 253-258
6 p.
|
artikel
|
| 77 |
Targeting the p40 cytokines interleukin (IL)-12 and IL-23 in Crohn's disease
|
Veldman, Geertruida M.
|
|
2006
|
|
3 |
p. 375-380
6 p.
|
artikel
|
| 78 |
Targeting the RAAS for the treatment of atherosclerosis
|
Ferrario, Carlos M.
|
|
2005
|
|
3 |
p. 221-229
9 p.
|
artikel
|
| 79 |
Targeting therapy in psoriatic arthritis
|
Mease, Philip J.
|
|
2004
|
|
3 |
p. 389-396
8 p.
|
artikel
|
| 80 |
Targeting the vascular RhoA–Rho-kinase signaling pathway in hypertension
|
Teixeira, Cleber E.
|
|
2005
|
|
3 |
p. 193-199
7 p.
|
artikel
|
| 81 |
The coagulation factor lottery – Is 9 the winning number?
|
Feuerstein, Giora Z.
|
|
2005
|
|
3 |
p. 279-283
5 p.
|
artikel
|
| 82 |
The effective treatment of COPD: Anticholinergics and what else?
|
Cazzola, Mario
|
|
2006
|
|
3 |
p. 277-286
10 p.
|
artikel
|
| 83 |
The endogenous control of acute inflammation – from onset to resolution
|
Gilroy, Derek W.
|
|
2004
|
|
3 |
p. 313-319
7 p.
|
artikel
|
| 84 |
The gut microbiota and disease – an inner repository for drug discovery
|
Shanahan, Fergus
|
|
2007
|
|
3 |
p. 195-200
6 p.
|
artikel
|
| 85 |
Therapeutic modulation of microRNAs
|
Chau, B. Nelson
|
|
2013
|
|
3 |
p. e127-e132
nvt p.
|
artikel
|
| 86 |
Therapeutic strategies for refractory systemic lupus erythematosus
|
Sidiropoulos, Prodromos I.
|
|
2004
|
|
3 |
p. 375-382
8 p.
|
artikel
|
| 87 |
Therapeutic strategies in polymyositis and dermatomyositis
|
Vencovský, Jiří
|
|
2004
|
|
3 |
p. 369-374
6 p.
|
artikel
|
| 88 |
Therapeutic strategies targeting interleukin-1 in vascular inflammation
|
Adamson, Peter
|
|
2006
|
|
3 |
p. 367-373
7 p.
|
artikel
|
| 89 |
Therapeutic targeting of Toll-like receptors
|
Uematsu, Satoshi
|
|
2004
|
|
3 |
p. 299-304
6 p.
|
artikel
|
| 90 |
Therapeutic T-cell-based vaccination versus pharmacological intervention for neuroprotection: restoring lost homeostasis
|
Schwartz, Michal
|
|
2004
|
|
3 |
p. 281-286
6 p.
|
artikel
|
| 91 |
Therapy of inflammatory airway disease: New horses for some old and some new courses
|
Goldie, Roy G.
|
|
2006
|
|
3 |
p. 251-252
2 p.
|
artikel
|
| 92 |
Toll-like receptors and airway disease
|
Hoffjan, Sabine
|
|
2006
|
|
3 |
p. 317-324
8 p.
|
artikel
|
| 93 |
Tumor-associated macrophages (TAMs) as new target in anticancer therapy
|
Mantovani, Alberto
|
|
2006
|
|
3 |
p. 361-366
6 p.
|
artikel
|
| 94 |
Tumour necrosis factor-α as a therapeutic target in asthma
|
Morjaria, Jaymin B.
|
|
2006
|
|
3 |
p. 309-316
8 p.
|
artikel
|
| 95 |
Where, when and how – the importance of advanced immunological screening in vivo in drug discovery
|
McInnes, Iain B.
|
|
2004
|
|
3 |
p. 287-291
5 p.
|
artikel
|
Tijdschrift beschrijving